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Abstract
Mitochondrial homeostasis is critical in meeting cellular energy demands, shaping calcium signals and determining
susceptibility to apoptosis. Here we report a role for anxA6 in the regulation of mitochondrial morphogenesis, and show
that in cells lacking anxA6 mitochondria are fragmented, respiration is impaired and mitochondrial membrane potential is
reduced. In fibroblasts from AnxA62/2 mice, mitochondrial Ca2+ uptake is reduced and cytosolic Ca2+ transients are
elevated. These observations led us to investigate possible interactions between anxA6 and proteins with roles in
mitochondrial fusion and fission. We found that anxA6 associates with Drp1 and that mitochondrial fragmentation in
AnxA62/2 fibroblasts was prevented by the Drp1 inhibitor mdivi-1. In normal cells elevation of intracellular Ca2+ disrupted
the interaction between anxA6 and Drp1, displacing anxA6 to the plasma membrane and promoting mitochondrial fission.
Our results suggest that anxA6 inhibits Drp1 activity, and that Ca2+-binding to anxA6 relieves this inhibition to permit Drp1-
mediated mitochondrial fission.
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Introduction
The annexins constitute a family of Ca2+ binding proteins with
diverse intracellular and extracellular functions that include roles
in vesicle transport [1] and inflammation [2]. Annexin A6 (anxA6)
has been shown to have a range of activities in cultured cell lines,
including the modulation of intracellular Ca2+-signalling in
epithelial cells [3], Ras inactivation via membrane targeting of
p120GAP [4], and the movement of cholesterol from late
endosomes to the Golgi and plasma membrane [5]. However,
mice containing a homozygous deletion of the AnxA6 gene do not
exhibit any overt phenotype, have a normal lifespan and are fertile
[6], indicating that either some of the proposed functions of anxA6
are restricted to cultured cells, or that compensatory mechanisms
mitigate the loss of anxA6 in vivo. Despite having a mild
phenotype, we have shown that cardiomyocytes from the
AnxA62/2 mice are more contractile and exhibit an accelerated
removal of diastolic Ca2+ from the cytoplasm [7]. These
observations suggest a negative inotropic role for cardiac anxA6,
and are consistent with transgenic studies in which cardiomyocyte-
specific over-expression of anxA6 led to a reduction in the
amplitude of Ca2+ transients, impaired contractility and cardio-
myopathy [8].
Although the mechanism whereby anxA6 modulates Ca2+
signals is not understood, there are many reports of annexins
acting both as regulators of cytosolic Ca2+ fluxes and also as Ca2+
channels themselves [9,10]. Whilst evidence for the latter is
derived solely from experiments using artificial lipid membranes
[11], it is clear that annexins can influence Ca2+ signals in cells in
various ways, including trafficking of channels to the plasma
membrane [12], modulation of the cytoskeleton [13] and by direct
physical interaction [14]. Here we sought further insight into the
role of anxA6 as a regulator of Ca2+ signalling, and observed
marked differences in mitochondrial ultrastructure in cells and
tissues from control and AnxA62/2 mice. Spatial organisation of
the mitochondrial reticulum is crucial for Ca2+ homeostasis and
influences cellular susceptibility to apoptosis [15–17]. We find that
mitochondrial morphology is abnormal in cells lacking anxA6,
Ca2+ signalling and respiration are impaired, and cells have
increased resistance to Ca2+-mediated apoptosis. Further, we show
that a pool of anxA6 associated with mitochondria binds to and
inhibits the fission GTPase Drp1, and that elevation of in-
tracellular Ca2+ relieves this inhibition by targeting anxA6 to the
plasma membrane. Our studies reveal a new function for anxA6,
and a novel mechanism of Ca2+-dependent regulation of Drp1.
Results
Mitochondrial Fragmentation in Cells Lacking AnxA6
Since mitochondria have a critical role in shaping Ca2+ signals
[18] we examined mitochondrial morphology and function in
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primary ear fibroblasts from AnxA62/2 mice and control
littermates, and A431 epithelial carcinoma cells (since this cell
line does not express anxA6 [3]). Cells were initially labelled either
with Mitotracker Red, mitochondrial-targeted GFP (mtGFP), or
immunostained with antibodies to the mitochondrial marker
cytochrome c (Cyto-c). Mitochondria were then scored visually
according to morphology as tubular/elongated, intermediate or
fragmented. In control mice, 8964.4% of ear fibroblasts exhibited
tubular/elongated mitochondria with only a few cells containing
fragmented mitochondria. In contrast, only 1962.7% of AnxA62/
2 cells had tubular mitochondria, almost 20% were fragmented,
while the majority displayed an intermediate phenotype (Figure 1,
A and B). Similar results were observed in A431 cells using both
mtGFP and immunostaining with antibodies to Cyto-c to visualise
mitochondria (Figure 1C). Western blot analysis confirmed the
expression of anxA6 in the stable line, and the absence of anxA6 in
the control-transfected wild type cells. The faint band migrating
slightly slower than anxA6 in the control cells is most likely weak
cross-reactivity with the anxA1 dimer. Thus, wild-type A431 cells
lacking anxA6 exhibited mostly fragmented mitochondria whereas
ectopic expression of anxA6 in these cells led to the appearance of
a tubular mitochondrial reticulum. The effects of anxA6 on
mitochondrial morphology were not an artefact of cell culture ex
vivo, since electron microscopy of mitochondria in skin fibroblasts,
liver and retinal pigment epithelial (RPE) cells from the AnxA62/2
mice showed a rounder, less elongated form, and in RPE cells the
mitochondria were also less electron-dense (Figure 2).
To determine how the subcellular localisation of anxA6 related
to mitochondrial morphology, we performed western blotting and
confocal microscopic analysis of purified mouse liver mitochondria
and primary mouse fibroblasts respectively. Most annexins are
predominantly soluble and cytosolic [10]. Consistent with this,
immunoblotting revealed both anxA6 and anxA2 in cytosolic
fractions purified from mouse liver. However, only anxA6 was also
present in the mitochondrial fraction, demonstrating that the
mitochondrial association of anxA6 is specific and not a generic
annexin property. Moreover, anxA6 was retained in the
mitochondrial fraction following exhaustive washing with the
Ca2+ chelator EGTA (Figure 3A), revealing the interaction with
this organelle to be Ca2+-independent. The association of anxA6
with mitochondria was further confirmed by confocal microscopy,
which identified co-localisation with Cyto-c in control mouse ear
fibroblasts (Figure 3B). The specificity of the anxA6 antibody was
verified by the absence of staining in AnxA62/2 mouse ear
fibroblasts (Figure 3C).
Loss of AnxA6 Disrupts Ca2+-signaling and Mitochondrial
Bioenergetics
To determine whether the mitochondrial fragmentation seen in
AnxA62/2 fibroblasts affected intracellular Ca2+ homeostasis and
signaling we examined mitochondrial Ca2+ uptake and cytosolic
Ca2+ transients following stimulation of control and AnxA62/2
fibroblasts with ATP (Figure 4, A and B). To this end, cells were
loaded with the fluorescent dyes Xrhod-1 and Fluo-4 AM to
concomitantly monitor Ca2+ signals in the two compartments. The
traces and the plotted peak values show that mitochondrial [Ca2+]
transients were reduced in AnxA62/2 cells (grey trace) compared
to control cells (black trace) - the relative increase in Xrhod signal
in response to ATP fell from 1.8760.12 in AnxA6+/+ cells to
1.5660.22 in the AnxA62/2 cells * = p,0.05, n= 3). In contrast,
cytosolic [Ca2+] transients were increased in AnxA62/2 cells
compared to controls, such that the relative Fluo-4 peak response
rose from 1.9760.17 in AnxA6+/+ cells to 2.4160.25 in the
AnxA62/2 cells **p,0.005, n = 4). Therefore the decreased
mitochondrial Ca2+ uptake reflects a specific mitochondrial defect,
and not a global decrease in Ca2+ signalling.
Figure 1. Mitochondrial morphology is abnormal in anxA6 null cells. (A) Images of primary fibroblasts from AnxA62/2 mice immunostained
for cytochrome c and analysed by confocal microscopy to visualise mitochondria. (B) Mitochondrial morphology was graded as tubular, intermediate
or fragmented for AnxA62/2 and control mice. Data represent the mean 6 s.d. of 3 independent experiments, with .1000 cells counted for each
strain. (C) A431 cells were either labelled in vivo with mitochondrial-targeted GFP (mtGFP), or labelled following fixation with antibodies to Cyto-c.
Cells were counter-stained using DAPI and visualised by confocal microscopy. Representative images show that mitochondrial staining is fragmented
in control A431 cells, but tubulated in A431 cells stably expressing AnxA6. Scale bar = 2 mm. The western blot shows expression of the larger isoform
of anxA6 only in the stable transfected cells.
doi:10.1371/journal.pone.0053774.g001
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Measurements of mitochondrial membrane potential (DYm)
using the potentiometric dye TMRM revealed that DYm was
significantly reduced in AnxA62/2 cells with a 54% decrease in
TMRM fluorescence signal (Figure 4C) *** = p,0.001, n = 36).
The reduced DYm may account for the attenuated mitochondrial
[Ca2+] uptake in AnxA62/2 cells, reflecting a decreased driving
force for Ca2+ accumulation [19]. Inhibition of the F1-FoATP
synthase using oligomycin, caused a loss of DYm in the AnxA6
2/2
cells rather than the expected increase in potential seen in control
cells (Figure 4C), showing that in the AnxA62/2 cells DYm is
maintained by the reversal of the ATP synthase which operates as
a proton pumping ATPase. This suggests that loss of AnxA6
causes a bioenergetic defect – such that the DYm is sustained
instead by the activity of the ATPase [20,21]. To further
investigate the change in mitochondrial physiology, NADH
autofluorescence was measured as an index of mitochondrial
redox state. NaCN and FCCP were employed to establish the full
dynamic range of the NADH fluorescence signal as the maximally
reduced and maximally oxidized signals respectively. The resting
level was defined in relation to these signals, thus indicating the
resting state of the NAD+/NADH pool which we will refer to as
‘redox index’ (Figure 4D). The NADH/NAD+ redox state was
significantly more oxidized in AnxA62/2 cells than the controls
(AnxA6+/+ cells: 1; AnxA62/2 cells: 0.6560.051, * = p,0.05,
n = 39). The combination of a reduced potential and a more
oxidised redox state strongly suggests a degree of uncoupling in
cells lacking AnxA6.
Close apposition between ER and mitochondria is critical for
the efficient exchange of Ca2+ between these compartments
following elevation of intracellular Ca2+ mediated by InsP3
[18,22]. To find out whether the anomalous patterns of Ca2+
signalling observed in cells lacking anxA6 could be due to changes
in ER-mitochondria connectivity we used immunofluorescence to
examine the distribution of Mfn2 [23], which localises to
mitochondria-ER contact sites [24]. We compared this with the
staining pattern of the Optical Atrophy 1 (Opa 1) protein which is
involved in the folding of the inner mitochondrial cristae [25] and
thus represents a suitable readout for the structural integrity of the
mitochondrial network (Figure 5A). Quantitative image analysis
revealed significantly reduced co-localisation of these two proteins
in AnxA62/2 fibroblasts than control cells, suggesting a decrease in
ER-mitochondria contact sites (AnxA6+/+: 90.2868.36%; AnxA62/
2: 75.7868.20%; n= 2 cells). The loss of ER-mitochondria
contact sites was not the consequence of a non-specific loss of
mitochondrial integrity, as the localisation of Tim23 was un-
affected in anxA6 null cells (Figure 5B). The loss of mitochondria-
ER contact sites is consistent with the observation that mitochon-
drial Ca2+ uptake is defective in AnxA62/2 fibroblasts, and may
also explain our previous report that EGF-induced Ca2+ transients
in A431 cells are attenuated by ectopic expression of anxA6 [3].
AnxA6 Modulates Cellular Susceptibility to Apoptosis
Since defects in mitochondrial Ca2+ handling would also be
expected to influence cellular susceptibility to apoptosis, we next
examined the effects of loss of anxA6 on the response of primary
mouse ear fibroblasts to the Ca2+ ionophore ionomycin. TUNEL
staining, PARP cleavage and nuclear translocation of Bax were
used as read-outs for apoptosis. After 24 h in the presence of 1 mM
ionomycin a significant number of control cells became rounded,
whereas anxA6 null fibroblasts appeared morphologically normal
(Figure 6, A and B). Fluorescence microscopy revealed fewer
TUNEL positive anxA6 null cells compared to control cells
following ionomycin treatment (Figure 6C). This was confirmed by
quantification by flow cytometry, which showed that 9067.4%
control cells were positive on TUNEL staining, whereas fewer
than 5% of AnxA62/2 fibroblasts were positive (Figure 6D).
Consistent with these observations, western blotting of cells treated
as above showed marked PARP cleavage [26] in control but not in
AnxA62/2 fibroblasts (Figure 6E). Nuclear translocation of Bax,
concomitant with that towards mitochondria, has also been
reported in cells undergoing apoptosis [27]. Here, we observed
Figure 2. Mitochondrial structural abnormalities in AnxA62/2mice. Sections of skin, liver and retina were prepared from control and AnxA62/
2 mice and examined by electron microscopy. Mitochondria (m) were enlarged and rounded in all tissues, and in retinal pigment epithelial cells (RPE)
appeared less electron-dense. Pigment granules in the RPE are also indicated (pg). Scale bar = 500 nm.
doi:10.1371/journal.pone.0053774.g002
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that .60% of control cells exhibited nuclear Bax, compared to
,30% of AnxA62/2 fibroblasts following ionomycin stimulation
(Figure 6F). Collectively these data show that when assessed using
a variety of read-outs, loss of anxA6 leads to increased resistance to
Ca2+-dependent apoptosis. This may be relevant in certain cancers
where loss of AnxA6 correlates with tumorigenesis and a more
malignant phenotype [28,29].
AnxA6 Binds to Drp1
Mitochondrial fragmentation is frequently observed at the
onset of apoptosis [30], and has thus become associated with
increased susceptibility to apoptosis. Although this appears to
run contrary to the data shown in Figure 6, there are
exceptions to this paradigm [31]. In particular, mitochondrial
fission induced by over-expression or activation of Drp1 leads
specifically to resistance to Ca2+-dependent apoptosis [32].
Interestingly, such manipulation of Drp1 mediates the opposite
effect with regard to apoptosis triggered by stimuli acting
through other pathways [32–34]. This prompted us to examine
whether the fragmentation of mitochondria in cells lacking
anxA6 is due to an imbalance in the large GTPases, in
particular Mfn2, Drp1 and Opa1. To determine whether anxA6
Figure 3. Partial co-localisation of AnxA6 to mitochondria. (A) Mitochondria (M) and cytosol (C) were purified from normal mouse liver and
western blotted for AnxA6 and AnxA2. The mitochondrial samples were immunoblotted following repeated washes (lanes w1-w4 show protein in
each wash) in buffer containing 1 mM EGTA, as were whole liver cell extracts from control (WT) and AnxA62/2 (KO) mice. (B) Normal primary mouse
fibroblasts were co-immunostained for AnxA6 and cytochrome C and analysed by confocal microscopy. Insets show partial co-localisation of AnxA6
and Cyto-c on mitochondria. (C) Primary mouse fibroblasts were isolated from the ears of AnxA62/2 mice and fixed and immunostained for AnxA6
and Cyto-c The images show faint non-specific staining with the AnxA6 antibody, and the characteristic pattern of fragmented mitochondria (see
inset). Scale bar = 4 mm.
doi:10.1371/journal.pone.0053774.g003
Annexin A6 and Mitochondrial Morphogenesis
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e53774
exerts its influence on mitochondrial morphogenesis via
a physical interaction with any of these molecules, we
performed co-immunoprecipitation experiments with antisera
to Drp1, Mfn2 and Opa1, followed by western blotting with
antisera to anxA6 (Figure 7, A and B). Immunoprecipitates (IPs)
were conducted using cell lysates prepared from both mouse ear
fibroblasts and mouse liver. First, we looked for evidence of
interactions between Drp1 and the other two GTPases. In these
experiments we used Drp1 antibodies to immunoblot the first
pellet wash (w1), the final pellet wash (w7– to ensure no
detectable protein carried through), and the IP (Figure 7A).
Drp1 was detected in each case in the first but not in the final
wash, and only in the Drp1 IP, showing that Drp1 does not
interact with either Mfn2 or Opa1. Next, using a similar
protocol we immunoblotted Drp1, Mfn2 and Opa1 IPs for
anxA6 (Figure 7B). These experiments revealed the presence of
anxA6 in Drp1 IPs but not in those for Mfn2 or Opa1, showing
that anxA6 forms a physical association with Drp1.
We then examined the expression and mitochondrial
targeting of Drp1 in cells lacking anxA6, and observed both
increased expression of Drp1 in whole cell lysates, and increased
association of Drp1 with purified liver mitochondria from
AnxA62/2 mice (Figure 7C). In contrast the mitochondrial
protein Tim23 was expressed at the same level in all samples
tested, suggesting that absolute mitochondrial load is apparently
unchanged as a consequence of AnxA6 gene knock-out. When
control and anxA6 null fibroblasts were co-stained for Drp1 and
Cyto-c, we observed a significantly higher level of Drp1
immunoreactivity localised to mitochondria in AnxA62/2
fibroblasts (Figure 7, D and E). These observations suggest that
anxA6 inhibits the targeting of Drp1 to mitochondria, and that
in cells lacking anxA6 Drp1 associates with mitochondria and
Figure 4. Ca2+ signalling and mitochondrial physiology defects in cells lacking anxA6. (A) Cytosolic Ca2+ transients in AnxA6+/+ and
AnxA62/2 fibroblasts in response to ATP measured with Fluo-4. The pooled data are shown in the adjacent histograms comparing peak responses. (B)
Representative traces of mitochondrial Ca2+ uptake in AnxA6+/+ and AnxA62/2 fibroblasts with histogram summarizing relative values assessed with
XRhod-1 in response to stimulation with the IP3 generating stimulus ATP (100 mM) in both cell types. (C) DYm in AnxA6+/+ and AnxA62/2 ear
fibroblasts was measured in cells equilibrated with 50 nM TMRM under resting conditions. The TMRM intensity, normalized to that of the AnxA6+/+
cells demonstrates a reduction in potential in AnxA62/2 cells. In response to oligomycin, DYm increased in AnxA6+/+ cells but decreases in the
AnxA62/2 cells, suggesting that DYm is maintained by a reversal of the F1-FoATPsynthase. (D) NADH autofluorescence was measured and
consecutive additions of NaCN and FCCP were used to establish the dynamic range of the signal and to normalize the resting state in relation to the
maximally reduced and maximally oxidised signals (respectively). The normalized values show that the NADH redox state was more oxidized in
AnxA62/2 cells consistent with a degree of uncoupling.
doi:10.1371/journal.pone.0053774.g004
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drives fission. In A431 cells stably expressing anxA6 we
observed marked co-localisation of anxA6 and Cyto-c, consistent
with data in Figure 3B, with Drp1 staining appearing punctate
at sites of mitochondrial association (Figure 7F). Stimulation of
these cells with ionomycin led to translocation of anxA6 from
intracellular sites, including mitochondria, to the plasma
membrane (Figure 7G). The behaviour of anxA6 in this context
is in line with the general paradigm that annexins become
membrane-associated upon elevation of intracellular Ca2+
[1,10]. Numerous studies have described this phenomenon,
Figure 5. Loss of mitochondria-ER contact sites in AnxA62/2 cells. (A) Opa-1 and Mfn-2 co-localization in AnxA6+/+ and AnxA62/2 fibroblasts
mark the overlap between ER and mitochondria in the two cohorts of cells. Scale bar = 4 mm. (B) Primary mouse fibroblasts fixed and immunostained
for Tim23 and Cyto-c The images show co-localisation of Tim23 and Cyto-C in fibroblasts from both mutant and wild type mice, but with the
characteristic mitochondrial fragmentation in AnxA6 null cells. Scale bar = 5 mm.
doi:10.1371/journal.pone.0053774.g005
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Figure 6. AnxA6 null cells are resistant to Ca2+-induced apoptosis. (A) Primary mouse fibroblasts were isolated from the ears of control and
AnxA62/2 mice and exposed to 1 mM ionomycin for the times indicated. Phase contrast images (and insets) show rounding up of cells after 6 h. Scale
bar = 30 mm. (B) Quantification of round and flat cells (.1000 in 3 separate experiments). (C, D) Fibroblasts from control and AnxA62/2 mice were
incubated with 1 mm ionomycin for 6 h, then either labelled with propidium iodide (PI) and TUNEL stained for confocal imaging (C) or sorted by flow
cytometry (D) to quantify the number of apoptotic cells. Scale bar in C= 10 mm. (E) Lysates were prepared from cells as above, after various times in
ionomycin, and western blotted for PARP. The full-length protein (116 kDa) and cleavage product (89 kDa) are indicated. (F) Control and AnxA6 null
Annexin A6 and Mitochondrial Morphogenesis
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fibroblasts were exposed to ionomycin as in (C) then fixed and stained for Bax. Staining for Bax was either both nuclear and cytosolic (image 1) or
cytosolic (image 2). Cell populations (n $1300 cells in three separate experiments) were scored for each pattern of staining and the percentage of
cells displaying each phenotype were plotted in the histogram. Scale bar = 5 mm.
doi:10.1371/journal.pone.0053774.g006
Figure 7. AnxA6 regulates mitochondrial morphology via interaction with Drp1. (A, B) Whole cell lysates were prepared from control
mouse ear fibroblasts or liver) and immunoprecipitated (IP) with antibodies to Drp1, Mfn2 and OPA1 as indicated. For each blot, w1 corresponds to
input, and w2, w3 and w7 correspond to wash number. IP is the immunoprecipitate, and the position of AnxA6 is indicated. Blots were probed with
antisera to Drp1 (A) and AnxA6 (B), the position of which is indicated, and visualised using enhanced chemiluminescence. The band running beneath
AnxA6 in the Mfn2 and OPA-1 IP lanes is IgG heavy chain. (C) Purified mitochondria and whole cell lysates of liver and primary fibroblasts from control
(Wt) and AnxA62/2 (KO) mice were immunoblotted with antisera against Drp1 and the mitochondrial marker Tim23 as a control for loading. (D)
Fibroblasts from control and AnxA62/2 mice were immunostained with antisera to Drp1 (red) and the mitochondrial marker cytochrome C (green),
and analysed by confocal microscopy. The insets show reticular staining of Cyto C in control fibroblasts, with little co-localisation with Drp1
(visualised in orange), in contrast to increased co-localisation of the two proteins in the AnxA6 null cells. Scale bar = 5 mm. (E) The proportion of Drp1
immunofluorescence coincident with Cyto-c was calculated using Metamorph, and is presented as mean 6 s.d., n = 3000 cells in 3 separate
experiments, *p,0.05. (F) A431 cells stably expressing AnxA6 were triple stained for AnxA6 (green), Drp1 (red) and Cytochrome c (magenta). Regions
that appear white in the lower right zoomed panel indicate coincidence of the three antigens. Scale bar = 2 mm. (G) A431 cells stably expressing
AnxA6 were simulated with 1 mm ionomycin for 5 min, then fixed and stained for AnxA6, Drp1 and Cytochrome c as in (F). Note that AnxA6 relocates
from the cytosol to plasma membrane in cells exposed to ionomycin (lower right ‘merge’ panel), with loss of regions of coincident staining of the
three proteins (seen as white in the top right ‘merge’ panel). Scale bar = 5 mm.
doi:10.1371/journal.pone.0053774.g007
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which is due to the specific affinity of annexins for negatively-
charged phospholipid headgroups in the presence of Ca2+
[13,35,36].
These observations suggest that inhibition of Drp1 in anxA6
null fibroblasts should be sufficient to reverse the mitochondrial
phenotype in those cells. To test this hypothesis we examined the
effects of a small molecule inhibitor of Drp1 named mdivi-1 [37]
on primary fibroblasts isolated from the AnxA62/2 mouse
(Figure 8). Cells were loaded with mitotracker and imaged at
various times upon exposure to mdivi-1. The results show that
over a 15 minute period there was a gradual increase in
connectivity within the mitochondrial reticulum that was not
observed in the DMSO control.
Discussion
Mitochondrial morphogenesis is under the dynamic control of
a large number of proteins, among which Drp1 is considered the
master regulator of mitochondrial fission [16]. Drp1 is itself subject
to regulation by multiple factors including Ca2+ and cAMP,
ubiquitylation and several interacting proteins. Elevation of
intracellular Ca2+ can stimulate phosphorylation of Drp1 on Ser
600 by CaM kinase Ia [38] as well as dephosphorylation of Drp1
on conserved serines 656 and 637 by calcineurin [39,40]. In each
instance Ca2+ stimulates translocation of Drp1 to mitochondria
and fragmentation. Here we provide evidence for a further
mechanistic link between Drp1, Ca2+ and mitochondrial network
morphogenesis, and suggest a model in which anxA6 constrains
mitochondrial fission by Drp1 at physiological Ca2+ levels.
The effects of anxA6 gene knock-out on mitochrondrial
morphogenesis are in part similar to those recently reported for
the novel mitochondrial outer membrane protein MIEF1/MiD51
[41,42]. As with MIEF1, over-expression of anxA6 in cells
normally lacking anxA6 led to extensive mitochondrial fusion,
whereas mitochondria in cells lacking anxA6 were highly
Figure 8. Inhibition of Drp1 reverses mitochondrial fragmentation in AnxA6 null fibroblasts. Primary mouse fibroblasts were isolated
from the ears of AnxA62/2 mice, loaded with Mitotracker, and exposed to DMSO (control) or 50 mM Mdivi-1 in DMSO for up to 15 min. Images were
captured on an inverted confocal microscope at 0, 2.5 and 5 min. The zoomed regions in the top panels show a marked increase in the number and
length of mitochondrial extensions (yellow arrows), in contrast to the DMSO treated cells in which the mitochondria remained mostly fragmented.
Scale bar = 5 mm.
doi:10.1371/journal.pone.0053774.g008
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fragmented (Figure 1). And like MIEF1, anxA6 is not expressed in
invertebrates [43], further emphasising the point that mitochon-
drial morphogenesis is differentially regulated in vertebrates and
yeast. There is no evidence that anxA6 is an integral mitochon-
drial membrane protein, but we identified a pool of anxA6 that is
tightly associated with mitochondria, remaining bound even after
exhaustive washing with Ca2+ chelator. The paradigm for
membrane binding by annexins is that it is Ca2+-dependent and
reversible, but there are well characterised exceptions to this
model such as the Ca2+-independent binding of anxA2 to
membranes enriched in phosphatidylinositol 4,5-bisphosphate
[44,45]. Here we showed that anxA2 is not associated with
mitochondria, demonstrating that this characteristic of anxA6 is
not a generic annexin property.
Division of the mitochondrial network disturbs the association
between mitochondria and intracellular sources of Ca2+, and thus
reduces mitochondrial Ca2+ uptake [32]. Although cell viability
isn’t affected in the absence of anxA6 such deficiency (or
adaptation) mediates protection against stress responses involving
ER/mitochondrial crosstalk and mitochondrial Ca2+ overload
such as programmed cell death induction via ionomycin.
Consistent with this, we observed enhanced resistance to Ca2+-
dependent apoptosis in anxA6 null fibroblasts, despite extensive
fragmentation of the mitochondrial network in these cells.
Interestingly, we previously showed that targeted deletion of the
AnxA5 gene in chicken DT40 cells similarly led to resistance to
Ca2+-dependent apoptosis [46], suggesting that these two annexins
may have specific and complementary activities in this context. In
cells lacking anxA6 we also observed a significant loss of
mitochondrial membrane potential. Given that anxA6 binds to
Drp1, we attribute this to deregulated activation of Drp1 since
work elsewhere has shown that over-expression of Drp1 in the
presence of an inducer of apoptosis inducer such as staurosporine,
is sufficient to accelerate the collapse of DYm [47,48].
In normal cells it is well established that mobilisation of
intracellular Ca2+ targets anxA6 to the plasma membrane [1,49],
which we propose here relieves the functional blockade of Drp1 by
anxA6 to permit Drp1-mediatedmitochondrial fragmentation. Our
results using primary cells from AnxA62/2mice show that loss of the
anxA6-Drp1 interaction is sufficient to drive mitochondrial fission
irrespective of changes in cytosolic Ca2+ concentration, and pre-
sumably therefore, the activities of othermodulators ofDrp1 and the
phosphorylation/dephosphorylation cyclementioned earlier. In this
delicate interplaybetweenstructureandsignalling,anxA6emergesas
an important regulator of themitochondrial fission factor Drp1 and,
through physical interaction with Drp1, may thus be central to
shaping Ca2+ responses in both normal and diseased cells.
Materials and Methods
Cells and Mice
AnxA6 null mutant mice and A431 cell culture techniques have
been described previously [3,6]. All animals were bred and
maintained by Biological Services in the UCL Institute of
Ophthalmology. The experiments described in this study were
carried out under licence from the UK Home Office and following
approval from the UCL Institute of Ophthalmology Ethical
Review Panel. The primary ear fibroblasts were isolated as follows
using two or three month old mice. Animals were killed by cervical
dislocation and quickly placed on ice. Ears were removed and
washed briefly in ice-cold 70% ethanol, followed by ice-cold PBS.
Hair and the epidermal layer of the skin were removed with
a medical scalpel and the ears washed once more in fresh ice-cold
PBS. Collagenase II (Worthington Biochemical) was prepared at
the working concentration of 2.5 mg/ml in serum-free DMEM.
Each ear was submerged in 1 ml of the collagenase solution
followed by fragmentation into small pieces with a fresh scalpel.
Fresh collagenase solution (4 ml) was added and the suspensions
resulting from the preparation of two ears were transferred to
a small cell culture bottle and incubated for up to 3 h at 37uC with
vigorous mixing every 15–30 min. The resulting cell suspension
was diluted 3x and transferred to 6–well culture dishes containing
22 mm cover slips treated with 70% ethanol followed by washing
in PBS. Each well was filled with 1 ml of diluted cell suspension
and 2 ml of fresh DMEM containing 10% FCS. Cells were
incubated at 37uC for 24 to 36 h before experimentation. This
procedure was applied on a regular basis unless the specific
requirements of an experiment dictated otherwise.
Immunofluorescence and Confocal Microscopy
The rabbit polyclonal antibodies to anxA6 have been described
previously [50]. For immunofluorescence studies antibodies were
diluted 1:100 and cells were used according to the following
protocol. Cells at 60–70% confluence were washed 2x with ice-
cold PBS containing a mixture of 0.1% Tween/0.1% Triton, and
then fixed in 3% ice-cold PFA for up to 10 min at room
temperature. Cells were washed quickly 2x in PBS, and 0.3%
Tween 20 and Triton X-100 was applied for up to 20 min to
achieve full permeabilisation of the cell surface as well as
intracellular organelles, in particular mitochondria. After permea-
bilisation, cells were washed 3x in PBS containing 0.1% Tween 20,
then briefly exposed to 50 mM NH4Cl followed by washing 2x in
PBS. Primary antibodies were applied for 2 h at room temper-
ature or overnight at 4uC. Labelled cells were washed up to 5x
with PBS containing 0.1% Tween 20 and incubated for up to 1 h
at room temperature with secondary antibodies, then washed
again up to 10x with PBS containing 0.01% Tween 20. The
labelling or co-labelling procedures including antibodies to Cyto-c
(mono- or poly, 1:500 and 1:1000 respectively, Santa Cruz), Drp1
(mono, 1:500, BD Biosciences), Opa1 (1:500, BD Biosciences),
Tim23 (1:500, BD Biosciences) and Mfn2 (1:1000, Santa Cruz)
followed a similar procedure with the only difference being that
Cytochrome C staining was always done overnight at 4uC and the
primary antibodies were never placed on cells simultaneously, but
sequentially with 2–3x washes with PBS containing 0.01% Tween
20 in between. The procedure for labelling cells with mitochon-
dria-targeted GFP employed a standard lipofectamine-based
protocol as describe elsewhere [51]. Mitotracker Green (Molecular
Probes) was applied according to the standard procedure for
primary cells. Cells loaded with mitotracker were incubated for
15–30 min at 37uC and washed up to 8x with warm PBS.
Immunofluorescence images were obtained on a Zeiss 510
confocal microscope and processed on Zeiss as well as Metamorph
software. Live images of mitotracker-labelled cells were obtained
on a Leica AOBS confocal microscope in the live-imaging mode
and processed on Velocity software. Mitochondria were purified
from mouse liver as described elsewhere [52].
Immunoprecipitation, Western Blotting and SDS-PAGE
The interactions between AnxA6 and other mitochondrial
factors were investigated by immunoprecipitation under non-
denaturing, [Ca2+] plus and [Ca2+] minus conditions. Cells and/or
organs of interest were lysed and prepared according to standard
procedures associated with the DynaBeads protocol. Lysates were
always pre-incubated with unconjugated beads for 10 min prior to
incubation with antibodies overnight at room temperature. Each
washing step was retained and checked on western blots. The
elution was cross-checked for the presence of the primary antibody
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as well as the presence of a putative interacting partner. Standard
western blotting procedures were applied following 10% SDS-
PAGE. Blots were incubated with antibodies diluted usually at the
concentration of 1:1000 (for primary antibodies) or 1:5000 (for
secondary antibodies) in 10% skimmed milk dissolved in DPBS
containing 0.01% Tween 20.
Apoptosis Measurements
To assess the susceptibility of AnxA6 knock-out cells to Ca2+ -
induced apoptosis, cells were exposed to 1 mM ionomycin for up
to 24 h and visually inspected for the appearance of a rounded
phenotype. To more precisely assess the induction of apoptosis,
ionomycin-exposed cells were tested with a standard TUNEL
protocol according to the manufacturer’s instructions (Cell
Signalling). Propidium iodide was used as contrast agent on
permeabilised cells. To further assess apoptosis, PARP labelling
was applied. The ionomycin-exposed control and AnxA6 knock-
out cells were lysed and samples were analysed by SDS-PAGE and
western blotting. Anti-PARP antibodies (Cell Signalling) were used
to assess the induction of apoptosis. Bax antibodies (Santa Cruz)
were used to study nuclear translocation in conjunction with
immunofluorescence labelling of control and AnxA6 knock-out cells
exposed to high concentration of ionomycin. Quantification of
signals from immunofluorescence analysis was performed on the
microscope by taking each picture 3x and averaging the intensity
of signals.
Mitochondrial Ca2+-measurements
Measurement of mitochondrial and cytosolic Ca2+ was executed
with the fluorescent dyes X-rhod and Fluo-4 AM. Primary
fibroblasts were co-incubated with the dyes (5 mM doses) and
0.002% (w/v) pluronic acid for 50 min at 37uC. The solution was
then removed and cells were washed twice with modified HBSS. A
fresh aliquot of modified HBSS (was added to the cells and each
cover slip of cells was mounted on an imaging chamber to be
affixed on the stage of the camera imaging system (Zeiss LSM-
510). Acquired images were analysed with the LSM and Image-J
Software.
Imaging of Mitochondrial Transmembrane Potential
(DYm)
We have conducted this experiment using the dye tetramethyl
rhodamine methyl ester (TMRM) as previously described [20] in
which the dye was present continuously at 50 nM. As a lipophilic
cation, TMRM equilibrates between compartments in a Nernstian
distribution, and so its concentration is a simple function of the
potential differences between the cellular compartments. It is
important to note that the TMRM fluorescence intensity is
measured by excluding all background signal by ‘thresholding’ and
then measuring the mean TMRM fluorescence intensity in the
pixels containing mitochondria. Thus the signal is independent of
mitochondrial mass and only reflects the dye concentration within
the mitochondria.
Assessing NADH Fluorescence as Mitochondrial Redox-
index
Using a Zeiss UV–visible 510 CLSM, NADH autofluorescence
was recorded from fibroblasts using excitation at 350 nm and
emission measured between 435 and 485 nm. Fibroblasts were
initially treated with the complex IV inhibitor NaCN to induce
a maximal reduction. When a steady was obtained NaCN was
washed out and replaced with standard recording buffer contain-
ing FCCP (1 mM) until the signals reached a steady state which
now reflects the maximal oxidation state. All data were then
normalized giving a set of data between ‘0’ (fully oxidised) and 1
(fully reduced) allowing us to obtain a value for the resting state
which we called the ‘redox index’. Data underwent a further
normalization setting the control as 1 to ease the graphic
representation.
Mdivi-1 Assay
Primary fibroblasts from AnxA62/2 and control mice were
isolated and cultured on Matek dishes at 37uC and 5% CO2 for 24
to 72 h in standard DMEM buffer supplemented with 10% FCS,
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamate
(Invitrogen). Cells were washed with 37uC PBS and exposed to
MitoTracker Green for 15–20 min at 37uC. MitoTracker Green
(Molecular Probes) was first diluted 100x in DMSO and 1 or 2 ml
of this solution were used per 2 ml of fresh 10% FCS DMEM
phenol red-free media to incubate with cells. After incubation cells
were washed 5–10 times in pre-warmed 25 mM HEPES buffer
pH 7.4, 150 mM NaCl, and 2 ml of phenol red-free 10% FCS
DMEM media supplemented with 25 mM HEPES buffer was
added to the cells. Cells were transferred to the pre-warmed (37uC)
Leica confocal microscope stage for live imaging of the
mitochondrial network. Mdivi-1 (Enzo Life Sciences) was added
to the media to a final concentration of 50 mM, mixed and
incubated for up to 15 min. Mdivi-1 was first diluted to 10 mg/ml
in DMSO and stored at -20uC. Mitochondrial network imaging
commenced immediately after adding the Mdivi-1 and continued
for up to 15 min. Control cells were exposed to 50 mM DMSO
only.
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